AL
ELOS

Airain Ltd’s Syneron Medical Ltd ELOS Stock Holding History

Airain Ltd’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$1.09M Buy
+100,000
New +$1.1M 0.05% 390

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Airain Ltd's ELOS Position: Q2 2017 in Review

Airain Ltd opened a new position in Syneron Medical Ltd (ELOS) in Q2 2017: 100,000 shares worth $1.09M. The stake represents 0.05% of the portfolio and ranks #390 among its holdings.

79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • Airain Ltd held 100,000 shares of Syneron Medical Ltd worth $1.09M as of Q2 2017.
  • Syneron Medical Ltd was a new Airain Ltd position in Q2 2017.
  • Syneron Medical Ltd made up 0.05% of Airain Ltd's portfolio in Q2 2017, its #390 holding.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.